Related by context. All words. (Click for frequent words.) 76 Files IND 75 Files Patent Application 75 Initiates Clinical Trial 74 FDA Clears 74 Immunomedics Announces 74 Announce Collaboration Agreement 74 Develop Innovative 74 Completes Patient Enrollment 74 Shows Promise Against 73 Initiates Enrollment 73 Successfully Completes Phase 73 Prolongs Survival 73 Molecular Diagnostic 73 Initiates Phase II 73 RNAi Therapeutic 73 Announce License Agreement 73 Postdoctoral Position 73 Patent Issued 73 Begins Shipment 73 Significantly Improves 72 platform HDL Mimetic 72 Test Detects 72 Initiates Clinical 72 Shows Promising 72 Small Molecule 72 Further Validates 72 Receives SFDA Approval 72 Announces FDA Clearance 72 Receives Patent 72 Neural Stem Cell 72 Initiates Dosing 71 Issued Patent 71 Presents Positive 71 Reduces Risk 71 Receives Orphan Drug Designation 71 Antitumor 71 Introduces Breakthrough 71 Introduces Novel 71 Novel Therapeutic 71 Meets Primary Endpoint 71 Completes Enrollment 71 Commercialize Novel 71 Expand Collaboration 71 Develop Novel 71 Presents Preclinical Data 71 Anti Tumor 71 Achieves ISO #:# Certification [002] 71 Inhibits 71 Accelerate Commercialization 70 Awarded Patent 70 Submits IND 70 Nicotine Vaccine 70 Novel Vaccine 70 Holds Promise 70 Commercializes 70 Initiates Clinical Trials 70 Obtains Patent 70 Develops Innovative 70 Demonstrates Significant 70 Tumor Targeting 70 Unveils Groundbreaking 70 Initiate Clinical Trial 70 Submits NDA 70 TB Vaccine 70 Therapeutic Competitors Companies 70 Collaborators Present 70 Treating Chronic 70 Receives Milestone Payment 70 Commences Phase 70 Present Preclinical Data 70 Receives Approvable Letter 70 Diagnostic Tests 70 Drug Resistant 70 Crit Rev 70 Shows Promise 70 Organometallic 70 Tuberculosis Vaccine 70 Secures Patent 70 Proves Effective 70 Proves Successful 70 Study Shows Benefits 70 Sign License Agreement 70 Demonstrates Sustained 70 Clinical Trial Results 70 RNAi Therapeutics 70 Protein Interactions 70 Therapeutic Agents 70 Immune Responses 70 Vascular Inflammation 69 Announce Collaboration 69 Phase 2b Clinical Trial 69 Therapeutic Vaccines 69 Oral Fluid 69 Significantly Improved 69 HCV Protease Inhibitor 69 Improves Quality 69 Helps Predict 69 Prove Effective 69 Photovoltaic Module 69 Therapeutic Vaccine 69 BioSante Pharmaceuticals Announces 69 Vaccine Adjuvant 69 Successfully Treated 69 Extends Collaboration 69 Technol 69 Demonstrates Statistically Significant 69 Receives CE Marking 69 Sign Licensing Agreement 69 Annu Rev 69 Identifies Potential 69 Modulates 69 Cancer Stem Cells 69 Drug Shows Promise 69 Guidelines Issued 69 FDA Okays 69 Malaria Vaccine 69 Announces Publication 69 Proven Effective 69 Protein Involved 69 Lowers Risk 69 Oral Calcitonin 69 Kinase Inhibitor 69 Improves Survival 69 ANADIGICS Announces 69 Scientists Develop 69 Osteoporosis Treatment 69 Antiviral Drugs 69 Receives FDA Clearance 69 Hsp# Inhibitor 69 Image Guided 69 Enters Into Exclusive 69 Synthetic Peptide 69 Retains CCG Investor Relations 69 Drug Candidate 69 Novel Oral 69 Taglich Brothers Initiates Coverage 69 Vaccine Protects Against 69 Awarded Patents 69 Biomolecules 69 Announce Initiation 69 Could Revolutionize 69 Introduces Next Generation 69 Endocrinol 69 Lanthanum Carbonate 69 Announce Licensing Agreement 69 Licenses Novel 69 Metabolic Disease 68 Antibody Discovery 68 Develops Breakthrough 68 Teva Provides Update 68 Announces Licensing Agreement 68 Drug Formulation 68 Cell Proliferation 68 Monoclonal 68 Hospital Acquired Pneumonia 68 AnaSpec Introduces 68 Seasonal Influenza Vaccine 68 Lupus Drug 68 Bone Metastases 68 Confirms Efficacy 68 Diabetic Foot Ulcer 68 Improves Outcomes 68 Demonstrates Positive 68 Gets FDA Clearance 68 siRNA Delivery 68 Submits Application 68 Molecular Diagnostic Test 68 Establish Joint Venture 68 Novel Method 68 Oral Interferon 68 Protease Inhibitor 68 Expands Capacity 68 Shown Effective 68 Prostate Cancer Vaccine 68 Recombinant Human 68 Achieves Milestone 68 Anticancer Drug 68 Issues Surrounding 68 Shows Efficacy 68 Submits Biologics License Application 68 High Growth Forecasted 68 Granted Orphan Drug 68 Protein Expression 68 IND Application 68 Systemic Delivery 68 Preclinical Data 68 Therapeutic Competitors Report 68 Preclinical Study 68 Strengthens Position 68 Effectively Treats 68 Successfully Concludes 68 Achieves ISO # 68 Anthrax Toxin 68 Tyrosine Kinase Inhibitor 68 Extracellular Matrix 68 Vaccine Candidate 68 Trial Evaluating 68 Initiate Phase III 68 Begin Clinical Trials 68 Method Developed 68 Immune Cells 68 Therapeutic Antibody 68 Monoclonal Antibody 68 Antigen Specific 68 Reports Preclinical Data 68 Unveils Innovative 68 Demonstrates Potential 68 Establishes Joint Venture 68 Cytometry 68 Dry Powder Inhalers 68 Awarded Qualifying Therapeutic 68 Identifies Key 68 Inflammatory Arthritis 68 BioElectronics Corporation Announces 68 Develop Next Generation 68 Announce Merger Agreement 68 Receives ISO #:# [002] 68 Transdermal Patch 68 Novel Antibody 68 Submits Response 68 Potent Antiviral Activity 68 Platform Enables 68 Expert Discusses 68 Obtains Exclusive License 68 Curr Opin 68 Begins Dosing 67 Anti Angiogenesis 67 Vaccine Adjuvants 67 Gene Expression Analysis 67 Molecular Mechanism 67 JAK2 Inhibitor 67 Completes Expansion 67 Immune Cell 67 Initiates Phase III 67 Optical Sensors 67 Obtains License 67 Anti Tumor Activity 67 Announce Breakthrough 67 Pathogen Detection 67 Collaborators Publish 67 Reduces Cost 67 Study Casts Doubt 67 Presents Positive Preclinical 67 Announces License Agreement 67 Recombinant Protein 67 Respiratory Virus 67 Pandemic Influenza Vaccines 67 Gastric Cancer 67 Anti CD# Antibody 67 AVI BioPharma Announces 67 Being Studied 67 Treatment Reduces 67 Mouse Models 67 Achieves Prestigious 67 Commercialize 67 FDA Approvals 67 Susceptibility Testing 67 Neuroprotection 67 Dendritic Cells 67 Successfully Tested 67 Attenuates 67 Further Strengthens 67 Renal Cancer 67 Efficacy Trial 67 Significantly Improve 67 Immunotherapeutic 67 PerkinElmer Acquires 67 Achieves Significant 67 Investigational Compound 67 Reduces Pain 67 Nerve Regeneration 67 Rotavirus Vaccine 67 Antibiotic Resistant 67 Genes Predict 67 Announces Initiation 67 Successfully Completed 67 Vaccine Shows Promise 67 Enters Into Collaboration 67 Signs Licensing Agreement 67 Receives Orphan Drug 67 Catheter Associated 67 Live Attenuated 67 Inflammatory Diseases 67 Transdermal Delivery 67 Flamel Technologies Announces 67 Improve Diagnosis 67 Demonstrates Superior 67 Announces Presentation 67 Therapeutic Efficacy 67 FDA Accepts 67 Lung Cancer Survival 67 Nanoemulsion 67 Advanced Melanoma 67 Boosts Productivity 67 Study Reinforces 67 Study Demonstrates 67 Extend Collaboration 67 Biomarker Study 67 Help Detect 67 Single Dose 67 Obtains Approval 67 Conjugates 67 Maven Semantic 67 Combination REOLYSIN R 67 NEC Develops 67 Successfully Treats 67 Appoints Experienced 67 Int J 67 Helps Identify 67 Plaque Psoriasis 67 Demonstrates Efficacy 67 MarketsandMarkets Global 67 Adjuvant Treatment 67 Ultrasensitive 67 Emphasizes Importance 67 Eur J 67 Achieves Unprecedented 67 Protein Biomarker 67 First Patient Dosed 67 Pandemic Flu Vaccine 67 Blood Clotting 67 Laryngeal Cancer 67 Slows Progression 67 Phase 2b Trial 67 Expands Portfolio 67 Could Prevent 67 Inks Licensing Deal 67 Artificial Liver 67 Autoantibodies 67 Provides Shareholder 67 Significantly Reduces 67 Novel Treatments 67 Commence Phase 67 Functional Proteomics 67 NMDA Receptor 67 Infected Patients 66 Genes Linked 66 Rheumatoid Arthritis Drug 66 Subsidiary Enters 66 Inflammatory Markers 66 Announces Immediate Availability 66 Phase IIa Clinical Trial 66 Oral Fingolimod 66 Underscores Importance 66 Significantly Increases 66 Levels Linked 66 Announces Poster Presentations 66 Provides Detailed 66 Introduces Revolutionary 66 Study Evaluating 66 Delivers Next Generation 66 Study Identifies 66 Randomized Clinical Trials 66 Genetic Screening 66 Bioresorbable 66 Researchers Develop 66 Study Indicates 66 Ebola Vaccine 66 Restructures Operations 66 Anti Inflammatory 66 Hematology Molecular Pathology 66 Initiates Phase 66 Lowers Blood Pressure 66 Anti Infective 66 Technological Advances 66 Secondary Hyperparathyroidism 66 Signs Merger Agreement 66 Pharmaceuticals Initiates 66 Secures Funding 66 FDA Warns Against 66 nasal decolonization 66 Therapeutic Competitors companiesandmarkets.com adEgemonye 66 Receives Clearance 66 Breast Tumor 66 Helps Prevent 66 Nanoporous 66 Nanofiber 66 Biopharmaceutical Manufacturing 66 Protein Interaction 66 Results Confirm 66 Unveils Revolutionary 66 Provides Comprehensive 66 SIX RO ROG 66 Lymphoid 66 AdVac ® PER.C6 ® 66 INDUSTRY ASSESSMENTS 66 Induces 66 ARRY # 66 Receives Certification 66 Achieves Primary Endpoint 66 Achieves ISO #:# Certification [001] 66 Retains CCG Elite 66 Patients Treated With 66 Preterm Labor 66 Scientists Unravel 66 Announces Divestiture 66 Antithrombin 66 Non Invasive 66 Study Proves 66 Strengthens Its 66 Expands Capabilities 66 Preclinical Models 66 Obtains Exclusive Rights 66 Showcases Latest 66 Announces Effective Date 66 J Allergy Clin 66 Clinical Outcome 66 Receives Recognition 66 Drug Combo 66 Virus Linked 66 Early Diagnosis 66 Treatment Shows Promise 66 Novel Antibiotic 66 Initiates Phase 2b 66 Viral Infections 66 Vitro Activity 66 J Clin 66 Signs Agreements 66 Patent Covering 66 Hepatitis B Virus 66 Human Antibody 66 Avian Flu Vaccine 66 Successfully Tests 66 Report Analyzes 66 Therapy Improves 66 Biologics Manufacturing 66 Genes Identified 66 Receives ISO #:# [001] 66 Confirms Commitment 66 Kinase Inhibitors 66 pralatrexate injection folate analogue 66 Non Invasive Treatment 66 Initiate Phase 66 Phase 2a Trial 66 Reportlinker Adds Global 66 Prolongs Life 66 Nanocomposite 66 Protein Linked 66 Human Neural Stem 66 Cardiac Rhythm 66 Homeostasis 66 Chemistries 66 Randomized Trials 66 Predict Response 66 ORLive Presents 66 Source Victhom Human 66 Provides Update Regarding 66 Jointly Develop 66 SPL# Gel vaginal microbicide 66 Antitumor Activity 66 DNA Methylation 66 Prevent Disease 66 Infectious Disease Testing 66 Reduced Risk 65 Psoriasis Drug 65 Appears Safe 65 Plasmid DNA 65 Mouse Model 65 contain Totally Degradable 65 Cervical Dysplasia 65 PRONTO Planning 65 Atopic Dermatitis 65 Hormone Receptor 65 Study Evaluates 65 Circulating Tumor Cells 65 Signaling Pathways 65 Announcement acc 65 Enters Into Licensing Agreement 65 Biocompatibility 65 Chronic Renal Failure 65 Diet Linked 65 Study Validates 65 Patents Covering 65 Manufacturer Selects 65 Vascular Grafts 65 Suppresses 65 Protein Synthesis 65 Introduces Unique 65 Schweitzer Mauduit Announces 65 Int J Radiat Oncol 65 Achieves Breakthrough 65 Autoimmune Disorders 65 Meta Analysis 65 STERIS Corporation Announces 65 Subtypes 65 Cancer Therapeutic 65 FDA Approves Drug 65 Lung Cancer Drug 65 Veeco Introduces 65 教育 展 65 Amino Acid 65 Oral Insulin 65 Pooled Analysis 65 Demonstrates Improved 65 Announces Discontinuation 65 Gout Drug 65 Demonstrates Interoperability 65 Intracellular 65 Fungal Infections 65 Laboratory Glassware 65 Interferon Alpha 65 Phase III Clinical Trial 65 Chronic Hepatitis B 65 Clinical Validation 65 Accelerates Growth 65 Factor Receptor 65 Researchers Identify 65 Naturally Occurring 65 Prostate Tumors 65 Introduces Enhanced 65 Aptamer 65 Prenatal Diagnosis 65 Hepatocellular Carcinoma 65 Immunotherapeutics 65 Guidelines Recommend 65 Novel Inhibitor 65 Novel Therapeutics 65 Biosynthetic 65 Drug Fails 65 Demonstrates Potent 65 Inflammatory Disease 65 Nat Clin Pract 65 Expands Scientific Advisory 65 Topical Treatment 65 Dose Response 65 Announces Issuance 65 Clinical Study Shows 65 Virus Infection 65 Amends Agreement 65 Molecular Pathogenesis 65 Therapeutic Potential 65 Unveils Breakthrough 65 Helps Diagnose 65 Ovarian Cancers 65 Severe Sepsis 65 Vitrasert R 65 Monoclonal Antibodies 65 Vitrasert ® 65 Licenses Patents 65 Makes Strides 65 Combination Therapy 65 Hematological Malignancies 65 Demonstrates Ability 65 Smallpox Vaccine 65 Impairs 65 products include BioNeutralizers 65 Vaccine Prevents 65 Invasive Fungal Infections 65 Announce Formation 65 Cholesterol Lowering 65 Continues Aggressive 65 Conjugated 65 Detect Cancer 65 candidates Azedra TM 65 Less Invasive 65 Electrically Conductive 65 Achieves Certification 65 Receives Positive 65 Breast Cancer Recurrence 65 Gluten Powder 65 Genes Involved 65 Clinical Trial Evaluating 65 Phase IIb Clinical Trial 65 Imaging Techniques 65 Develops Next Generation 65 Multidrug Resistant 65 Fortifies 65 Dosage Forms 65 Menopausal Symptoms 65 Provide Comprehensive 65 Announces Tentative Approval 65 Custom Synthesis 65 Tibotec BVBA 65 Neurosurg 65 Experts Convene 65 Mg Usa 65 Receives Funding 65 Orally Active 65 REMINDER ORLive Presents 65 Reveals Significant 65 J Pediatr 65 Endometrial Cancer 65 Thyroid Hormone 65 Inc Therapeutic Competitors 65 Signs License Agreement 65 Recommends Approval 65 - Aarkstore Enterprise [002] 65 Interferon Gamma 65 Adult Stem Cell Therapy 65 Orthop Surg 65 Dendritic Cell 65 Launches Next Generation 65 Prognostic Value 65 Metabolic Disorder 65 Submits Supplemental 65 Avian Influenza Vaccine 65 Stem Cell Treatment 65 Delivers Breakthrough 65 Mucosal 65 Cytotoxicity 65 Files Investigational 65 Adipose Derived Stem Cells 65 Electrophysiology Mapping 65 Alfacell proprietary ribonuclease 65 Voluntarily Withdraws 65 Psychol 65 Clinical Evaluation 65 KEMET Announces 65 Nuclear Receptors 65 Report Assesses 65 Significantly Enhances 65 Unveils Upgraded 65 Dose Ranging 65 研究 65 #:#-#,# CrossRef Medline [002] 65 #-# Full Text 65 Crofelemer budesonide foam 64 includes Dideco CarboMedics 64 Releases Enhanced 64 Stress Induced 64 Adjunctive Therapy 64 Retains Leading 64 Hematological Cancers 64 Phytochemical 64 Applied Polymer 64 Patient Enrollment 64 Gene Silencing 64 Eases Pain 64 First Patient Treated 64 Announce Definitive Agreement 64 Signal Transducers 64 Strengthens Leadership 64 Pharmacother 64 Receive Milestone Payment 64 Files Patent 64 MITTEILUNG UEBERMITTELT VON BUSINESS 64 Silicon Solar Cells 64 Exploit collaboration 64 Oral Formulation 64 HER2 Positive 64 Bacterial Cell 64 CIGS Solar 64 Seminar Focuses 64 Epitopes 64 Shows Statistically Significant 64 Contrast Agents 64 Slow Progression 64 Previously Untreated 64 Spider Silk 64 Potentially Fatal 64 Bionanotechnology 64 Countermeasures Against 64 Inovio Pharmaceuticals 64 Genetic Disorders 64 Autoimmune Diseases 64 Post Menopausal 64 Drug Prevents 64 Angiogenic 64 Chronic Hepatitis C 64 Provides Clues 64 Injectable Drug 64 Significant Milestone 64 Imaging Technique 64 Enters Into License Agreement 64 Receives Tentative Approval 64 Holds Inaugural 64 Reacquires 64 Combination Treatment 64 Thyroid Function 64 Magnetic Nanoparticles 64 Water Soluble 64 Relapsing Multiple Sclerosis 64 Successfully Demonstrates 64 Polymerase Inhibitor 64 Conjugate 64 Treatment Experienced 64 ARRIS Announces 64 Selects BoardVantage 64 Commercially Available 64 Neurotransmitter 64 Allergic Reactions 64 Antisense Drug 64 Enzyme Linked 64 Emphasizes Need 64 Genetic Variation 64 Tumor Growth 64 Prevalence Worldwide 64 Immunostimulatory 64 Skeletal Muscle 64 Receives Fast Track 64 Epilepsy Drug 64 Microfluidic Device 64 Small Molecules 64 MorphoSys AG FSE MOR 64 Oral Cavity 64 Completes Installation 64 Contrast Enhanced 64 Solid Oxide Fuel Cell 64 Cell Differentiation 64 Metastatic Melanoma 64 Inhaled Nitric Oxide 64 Telik Announces 64 Data Suggest 64 Revitalizes 64 Am J Clin 64 Unveils Latest 64 Critically Ill Patients 64 Successfully Demonstrate 64 Apoptotic 64 Terminates Contract 64 Rotavirus Vaccines 64 Showcases Innovative 64 Testing Capabilities 64 Therapeutic Targets 64 Awarded GSA 64 Oligonucleotide 64 Concludes Successful 64 Increases Productivity 64 Prognostic Factors 64 Highlight Importance 64 Cardiovascular Disease Risk 64 Introduces Powerful 64 Low Dose 64 Pivotal Study 64 Streamlines Operations 64 Innate Immune 64 Introduces Expanded 64 Cholinesterase Inhibitors 64 Enables Rapid 64 Restructures Debt 64 Adenoviral 64 Completes Acquisitions 64 Successfully Passes 64 Wound Dressings 64 Inc. LATEST NEWS 64 Breast Cancer Cells 64 Bacterial Infection 64 Parathyroid Hormone 64 methylnaltrexone bromide 64 Wound Dressing 64 Pre Cancerous 64 Nanoimprint Lithography 64 Artificial Skin 64 Launches Pioneering 64 Muscle Wasting 64 Nanopatterning 64 Adjuvanted 64 Balloon Catheters 64 Gene Linked 64 Could Save Lives 64 Receptor Signaling 64 vapreotide acetate 64 DayTradersDigest.com Profiles 64 Idenix Novartis 64 Misonix Announces 64 Hydrogen Generation 64 Launches Unique 64 Toshiba Develops 64 Internationally Recognized 64 Cell Adhesion 64 Scientists Uncover 64 Tumor Angiogenesis 64 Releases Next Generation 64 Tocopherol 64 Dengue Virus 64 Transfection 64 Antimicrobial Coating 64 Beneficial Effects 64 Taro Receives 64 Embedded NVM MEMS 64 Pathol 64 Antifungal 64 Completes Reverse Merger 64 Investigational Drug 64 Completes Successful 64 Demonstrated Significant 64 Finalizes Acquisition 64 Enrolls First 64 Dramatically Increases 64 Previously Treated 64 Increases Risk 64 Vildagliptin 64 Ink Pact 64 personalized dendritic 64 Reduces Mortality 64 Named Exclusive Distributor 64 Completes Merger With 64 Experimental Vaccine 64 Protein Therapeutics 64 AllPennyStocks.com Spotlights 64 Completes Recapitalization 64 Spray Drying 64 Flagship Product 64 Novel Compounds 64 Transdermal Drug 64 Therapeutic Antibodies 64 Asthma Treatment 64 Intravenous Human 64 Viral Load 64 Broadens Its 64 Receives Accreditation 64 Phase III Trial 64 Epstein Barr Virus EBV 64 Endothelial Cells 64 Sleep Disturbances 64 #nm Process 64 Provides Enhanced 64 Broadens Scope 64 Cardiovascular Monitoring 64 Barrier Repair 64 Biodegradable Plastic 64 Reports Positive 64 Helps Detect 64 Oncolytic 64 Genotyping Test 64 Study Concludes 64 Lyophilized 64 Could Predict 64 Inhaled Liposomal Ciprofloxacin 64 VIVITROL ® 64 Antibody Drug Conjugate 64 Provides Complete 64 Progenitor Cell 64 Single Molecule 64 Chemotherapeutic Agents 64 Improves Productivity 64 See CLINICAL PHARMACOLOGY 64 Migraine Treatment 64 Molecular Basis 64 Researchers Uncover 64 Achieve Breakthrough 64 Showed Significant 64 Regenerative Cell 64 Liposomal 64 CysDisplay R 64 Influenza Vaccine Production 64 Improves Efficiency 64 Anticancer Agent 64 Formulates 64 STMicroelectronics Unveils 64 Mylan Receives Approval 64 Thermally Conductive 64 Study Sheds Light 64 Solid Tumor 64 Desvenlafaxine Succinate 64 Drug Resistant Tuberculosis 64 Minimally Invasive Treatment 64 Receives Favorable Ruling 64 Colon Polyps 63 Announces Successful Completion 63 Achieves Record Sales 63 Announce Licensing 63 Miraculins Announces 63 Nucleic Acids 63 Renal Cell Cancer 63 Solution Combines 63 Markettelegraph.com 63 Acquires Exclusive 63 Accelerate Adoption 63 Could Detect 63 Hedgehog Pathway 63 Novel Mechanism 63 Masimo SET Signal Extraction 63 Completes Divestiture 63 Earns Milestone Payment 63 TVS Diodes 63 RealPennies.com RealPennies.com 63 Epithelial Cell 63 Iron Deficiency 63 Mutually Agree 63 segment Biotest 63 Commences Phase III 63 Tumor Cell 63 Lowers Cholesterol 63 Being Evaluated 63 Wafer polifeprosan 63 Skin Disorders 63 Toxicol 63 Cancer Cells 63 Hormone Receptor Positive 63 FDA Approves 63 Regenerative Cells 63 Achieves ISO 63 Cancer Incidence Mortality 63 Cell Transplants 63 Sees Steady 63 Significant Improvements 63 Vertebral Fractures 63 Unveils Expanded 63 Mimetics 63 Improve Survival 63 Cypher Sirolimus 63 Researchers Devise 63 MarketResearch.com Announces 63 Settle Patent Litigation 63 Immunodiagnostics 63 EXECUTIVE SUMMARY II 63 Contrast Agent 63 Ovarian Cancer Treatment 63 Oxidative Stress 63 GRAS Status 63 Expands Scope 63 Microstructure 63 Wafer Bonding 63 License Pact 63 Neutrolin ® 63 Confirms Significant 63 Myelodysplastic Syndromes 63 Freeze Drying 63 Files Shelf Registration Statement 63 Embosphere R 63 Pluripotent Stem Cells 63 J Shoulder Elbow 63 Cogn 63 Respiratory Syncytial Virus RSV 63 Breast Tissue 63 Announce Completion 63 Announce Launch 63 Cardiovasc 63 Hepatitis C Virus 63 VIVUS Announces 63 Zenith Optemedia Zeus 63 Cases Linked 63 Patients Receiving 63 Companion Diagnostics 63 Phase IIb Trial 63 Complete Merger 63 Immunol 63 Clinical Trial Data 63 Jointly Launch 63 #:#-# [023] 63 Complicated Skin 63 Poster Presentations 63 Services #:#-#,# Abstract 63 Tissue Engineered 63 Metabolic Disorders 63 J Nutr 63 Improves Accuracy 63 Genes Associated 63 Kidney Function 63 Strongly Linked 63 Raw #/#/# Punjab 63 Osteoporosis Drugs 63 听力 63 Clinically Significant 63 Highlights Importance 63 Antiviral Drug 63 Investigational Treatment 63 Novartis Novo Nordisk 63 Board Authorizes 63 Demonstrates Next Generation 63 Artificial Pancreas 63 Breast Cancer Metastasis 63 分析 63 Antibacterials 63 Demonstrate Innovative 63 考研 英语 63 Alvine Pharmaceuticals 63 Rated Speculative Buy 63 Polymorphisms 63 Replicates 63 Study Analyzes 63 Flow Cytometry 63 Neural Stem Cells 63 Neurotoxicity 63 Underscores Commitment 63 Analyte 63 Finalizes Purchase 63 Liver Transplant Patients 63 Receives Prestigious Award 63 Inks MOU 63 Regains NASDAQ 63 Aurora Kinase 63 Leukemia Cells 63 Penetrates 63 Toxicogenomics 63 Study Confirms 63 Treated Patients 63 PerkinElmer Introduces 63 Implantable Device 63 Exclusive License 63 Thewallstreetleader.com Profiles 63 Adjuvant Chemotherapy 63 Aeolus Pharmaceuticals Announces 63 Completes Transition 63 Announce Commencement 63 Progenitor Cells 63 Collaborates With 63 Researcher Develops 63 Chemotherapeutic 63 Assay Kits 63 Patients Suffering 63 Acrylate 63 SMARTREND NEWS 63 Jointly Announce 63 Carbon Nanotube Based 63 Announces Rebranding 63 Relapsed Refractory 63 Achieves Milestones